支气管热成形术对重症哮喘气道平滑肌及长期临床疗效的影响
该研究通过22例患者的配对数据分析,探讨支气管热成形术(BT)对气道平滑肌(ASM)质量及临床参数的2.5年影响。结果显示BT后2.5年ASM质量减少>50%持续存在,哮喘控制、生活质量和急性加重率持续改善,且残留ASM与急性加重率及支气管舒张后FEV1占预计值百分比相关。
要点
- BT后2.5年ASM质量减少>50%持续存在。
- 哮喘控制、生活质量和急性加重率持续改善。
- 残留ASM与急性加重率及FEV1占预计值百分比相关。
核心结论
- BT治疗重症哮喘后2.5年ASM质量减少>50%持续存在,临床改善持续,残留ASM与急性加重率及肺功能相关。
研究设计与样本
- 配对数据分析,纳入22例重症哮喘患者,评估BT后2.5年的ASM质量与临床参数。
主要发现
- BT后2.5年ASM质量减少>50%持续存在。
- 哮喘控制、生活质量和急性加重率持续改善。
- 残留ASM与急性加重率相关:desmin r=0.61,p=0.04;alpha-SMA r=0.85,p<0.01。
- 残留ASM与支气管舒张后FEV1占预计值百分比相关:desmin r=-0.69,p=0.03;alpha-SMA r=-0.58,p=0.08。
临床怎么用
- BT可能通过持续减少ASM质量带来长期临床获益,残留ASM或可作为疗效监测指标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The mechanism of action of bronchial thermoplasty (BT) treatment for patients with severe asthma is incompletely understood. This study investigated the 2.5-year impact of BT on airway smooth muscle (ASM) mass and clinical parameters by paired data analysis in 22 patients. Our findings demonstrate the persistence of ASM mass reduction of >50% after 2.5 years. Furthermore, sustained improvement in asthma control, quality of life and exacerbation rates was found, which is in line with previous reports. An association was found between the remaining ASM and both the exacerbation rate (r=0.61, p=0.04 for desmin, r=0.85, p<0.01 for alpha smooth muscle actin (SMA)) and post-bronchodilator forced expiratory volume in 1 s predicted percentage (r=-0.69, p=0.03 for desmin, r=-0.58, p=0.08 for alpha SMA). This study provides new insight into the long-term impact of BT.
引用
- Wijsman, Goorsenberg, d'Hooghe, et al. Airway smooth muscle and long-term clinical efficacy following bronchial thermoplasty in severe asthma. Thorax. 2024. PMID: 38346871. doi:10.1136/thorax-2023-220967
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。